☆ 4.7 Article

High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance

LEUKEMIA (2022)

Related references

Note: Only part of the references are listed.

Article Hematology

Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping

Katrina Rack et al.

Summary: Acute lymphoblastic leukemia (ALL) is a malignant disease that can be divided into distinct subtypes based on clinical and genomic features. Traditional diagnostic methods are laborious and costly. This study applied optical genome mapping (OGM) to diagnose ALL and found that OGM can accurately detect common genomic abnormalities, improve the detection rate and cytogenetic resolution, and reduce turnaround time.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Add to Collection

Article Pathology

Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group

Rashmi Kanagal-Shamanna et al.

Summary: The study revealed that patients with MDS/MPN-i(17q) were typically younger with lower platelet and neutrophil counts, commonly displayed bilobed neutrophils and had a higher mutation frequency. These patients had a poorer prognosis and shorter overall survival compared to those without i(17q).

MODERN PATHOLOGY (2022)

Add to Collection

Article Hematology

Guiding the global evolution of cytogenetic testing for hematologic malignancies

Yassmine M. N. Akkari et al.

Summary: Cytogenetics is crucial in the clinical evaluation of hematologic malignancies. Chromosome banding studies and novel sequencing technologies have advantages and limitations, and their implementation in the global clinical setting requires consideration of clinical, logistic, technical, and financial factors.

BLOOD (2022)

Add to Collection

Article Genetics & Heredity

Hybrid sequencing resolves two germline ultra-complex chromosomal rearrangements consisting of 137 breakpoint junctions in a single carrier

Jesper Eisfeldt et al.

Summary: This study reported a healthy female carrying two novel CCRs and characterized these complex rearrangements. The results were validated using multiple cytogenetic methods, revealing the highest number of breakpoint junctions (137) and indicating an association between CCR formation and active gene transcription.

HUMAN GENETICS (2021)

Add to Collection

Article Oncology

Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myelodysplasies (GFM)

Thomas Cluzeau et al.

Summary: The combination of Eprenetapopt with AZA showed potentially higher overall response rate (ORR) and complete remission (CR) rate, as well as longer overall survival (OS) in untreated high-risk TP53m MDS and AML patients, with main treatment-related adverse events being febrile neutropenia and neurologic adverse events.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers

Eric J. Duncavage et al.

Summary: This study showed that whole-genome sequencing provided rapid and accurate genomic profiling in patients with AML or MDS, with a greater diagnostic yield than conventional cytogenetic analysis, and more efficient risk stratification based on standard risk categories.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Genetics & Heredity

Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses

Nikhil Shri Sahajpal et al.

Summary: Optical genome mapping (OGM) is a novel technology that can detect all types of structural variations, addressing the limitations of traditional cytogenetic methods. Its potential to comprehensively identify genetic disorders in prenatal testing could reduce the global burden of genetic diseases.

GENES (2021)

Add to Collection

Article Oncology

Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias

Valentin Lestringant et al.

Summary: The study compared optical genome mapping (OGM) to standard techniques in detecting cytogenetic abnormalities in acute lymphoblastic leukemias (ALL). OGM showed higher accuracy and sensitivity, identifying anomalies not easily detectable by standard techniques.

GENES CHROMOSOMES & CANCER (2021)

Add to Collection

Article Genetics & Heredity

Optical genome mapping enables constitutional chromosomal aberration detection

Tuomo Mantere et al.

Summary: The study investigated the use of optical genome mapping (OGM) to detect known chromosomal aberrations, with results showing OGM's ability to accurately detect various types of chromosomal abnormalities, including complex rearrangements. High-resolution OGM achieved 100% concordance compared to standard assays for aberrations without centromeric breakpoints.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Add to Collection

Article Hematology

Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes

Sally B. Killick et al.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Editorial Material Hematology

Beyond morphology: to be or not to be an MDS

Mar Mallo et al.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Oncology

Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes

Rashmi Kanagal-Shamanna et al.

Summary: The subtype of SF3B1 mutation plays a key role in risk assessment and prognosis of MDS, with K700E mutation associated with a favorable outcome compared to non-K700E mutations. This highlights the importance of refining MDS subclassification based on different SF3B1 mutation subtypes.

CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia

Thomas Cluzeau et al.

Summary: This article reviews the progress in targeting TP53 mutated myelodysplastic syndromes and acute myeloid leukemia, focusing on the use of active agents and future treatment directions. It emphasizes the importance of understanding the clinical characteristics of the disease and the impact of TP53 mutant burden on patient clinical trajectory.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Oncology

Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors

Mariangela Sabatella et al.

Summary: In some pediatric cancers, a suspected germline cancer predisposition hinders genetic counseling and testing due to lack of genetic evidence. A study of a family with atypical teratoid rhabdoid tumor revealed a disruptive retrotransposon element in the SMARCB1 gene, undetected by standard techniques, showcasing the power of alternative sequencing methods in identifying complex genomic variations and improving clinical diagnosis and counseling.

JOURNAL OF PATHOLOGY (2021)

Add to Collection

Article Oncology

Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia

Zhenya Tang et al.

Summary: In this study, comparative analysis between CMA and traditional cytogenetic methods such as karyotyping and FISH revealed that CMA can provide additional analytical information but its clinical utility is limited to a small number of patients. Evaluation based on NCCN and CGC guidelines showed that combining FISH with CMA had higher capture rates of prognostic relevant cytogenetic information. Further research is needed to explore the potential of CMA as an alternative to karyotyping.

LEUKEMIA RESEARCH (2021)

Add to Collection

Article Oncology

The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia

Jonathan Lukas Luehmann et al.

Summary: This study investigates the feasibility of using Optical Genome Mapping (OGM) as an all-in-one approach to determine the genetic risk profile of childhood Acute Lymphoblastic Leukemia (ALL). OGM has the potential to simplify the diagnostic workflow and identify new structural variants helpful for classifying patients into treatment groups. The results show that OGM can detect both established and new potential prognostic markers in ALL, demonstrating its promise for future diagnostic applications.

CANCERS (2021)

Add to Collection

Letter Medicine, General & Internal

Genome Sequencing in Myeloid Cancers

Torsten Haferlach et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Hematology

Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management

Guillermo Garcia-Manero et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Optical mapping of the 22q11.2DS region reveals complex repeat structures and preferred locations for non-allelic homologous recombination (NAHR)

Steven Pastor et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Hematology

Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS

Anna Stengel et al.

BLOOD ADVANCES (2020)

Add to Collection

Article Hematology

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes

Guillermo Montalban-Bravo et al.

BLOOD ADVANCES (2020)

Add to Collection

Review Genetics & Heredity

Long-Read Sequencing Emerging in Medical Genetics

Tuomo Mantere et al.

FRONTIERS IN GENETICS (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Structural variant calling: the long and the short of it

Medhat Mahmoud et al.

GENOME BIOLOGY (2019)

Add to Collection

Article Hematology

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Eytan M. Stein et al.

BLOOD (2018)

Add to Collection

Editorial Material Hematology

Partial tandem duplication of KMT2A (MLL) may predict a subset of myelodysplastic syndrome with unique characteristics and poor outcome

Sarah M. Choi et al.

HAEMATOLOGICA (2018)

Add to Collection

Editorial Material Hematology

Partial tandem duplication of KMT2A (MLL) may predict a subset of myelodysplastic syndrome with unique characteristics and poor outcome

Sarah M. Choi et al.

HAEMATOLOGICA (2018)

Add to Collection

Review Hematology

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Hartmut Doehner et al.

BLOOD (2017)

Add to Collection

Article Oncology

Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)

Q-Y Sun et al.

LEUKEMIA (2017)

Add to Collection

Review Hematology

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber et al.

BLOOD (2016)

Add to Collection

Review Pathology

Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory

Rashmi Kanagal-Shamanna et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)

Add to Collection

Review Genetics & Heredity

Coming of age: ten years of next-generation sequencing technologies

Sara Goodwin et al.

NATURE REVIEWS GENETICS (2016)

Add to Collection

Article Hematology

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Elli Papaemmanuil et al.

BLOOD (2013)

Add to Collection

Editorial Material Oncology

Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q)

Rashmi Kanagal-Shamanna et al.

CANCER GENETICS (2013)

Add to Collection

Article Hematology

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg et al.

BLOOD (2012)

Add to Collection

Article Oncology

Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53

Rashmi Kanagal-Shamanna et al.

CANCER (2012)

Add to Collection

Article Oncology

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

Julie Schanz et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Add to Collection

Review Genetics & Heredity

Repetitive DNA and next-generation sequencing: computational challenges and solutions

Todd J. Treangen et al.

NATURE REVIEWS GENETICS (2012)

Add to Collection

Article Hematology

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies

Ramon V. Tiu et al.

BLOOD (2011)

Add to Collection

Review Genetics & Heredity

APPLICATIONS OF NEXT-GENERATION SEQUENCING Genome structural variation discovery and genotyping

Can Alkan et al.

NATURE REVIEWS GENETICS (2011)

Add to Collection

Article Medicine, General & Internal

Clinical Effect of Point Mutations in Myelodysplastic Syndromes

Rafael Bejar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Review Genetics & Heredity

Alu repeats and human genomic diversity

MA Batzer et al.

NATURE REVIEWS GENETICS (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.